Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pranlukast Hemihydrate

Known as: N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide Hemihydrate, SC-215745 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The possibility of newly developed α-glycosylated naringin (Naringin-G) as a solubilizing agent was investigated against… Expand
Is this relevant?
2015
2015
The present study was carried out to develop an oral formulation of pranlukast hemihydrate with improved dissolution and oral… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The purpose of the present investigation was to develop and evaluate a self-microemulsifying drug delivery system (SMEDDS) for… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2011
2011
The α-glucosyl hesperidin (Hsp-G)-induced improvement of both the dissolution and absorption properties of pranlukast hemihydrate… Expand
Is this relevant?
2007
2007
We prepared microparticles containing nanoparticles of water-insoluble pranlukast hemihydrate (PLH) using a 4-fluid nozzle spray… Expand
Is this relevant?